Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Times Interest Earned (2022 - 2025)

Coeptis Therapeutics Holdings (COEP) has 4 years of Times Interest Earned data on record, last reported at -$39.56 in Q3 2025.

  • For Q3 2025, Times Interest Earned rose 5.93% year-over-year to -$39.56; the TTM value through Sep 2025 reached -$47.12, down 361.55%, while the annual FY2024 figure was -$25.38, 37.28% up from the prior year.
  • Times Interest Earned reached -$39.56 in Q3 2025 per COEP's latest filing, up from -$66.7 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $1002.1 in Q4 2023 and bottomed at -$399.05 in Q3 2023.
  • Average Times Interest Earned over 4 years is -$13.33, with a median of -$56.75 recorded in 2025.
  • The widest YoY moves for Times Interest Earned: up 217.65% in 2023, down 304.33% in 2023.
  • A 4-year view of Times Interest Earned shows it stood at $315.47 in 2022, then soared by 217.65% to $1002.1 in 2023, then crashed by 102.74% to -$27.5 in 2024, then tumbled by 43.87% to -$39.56 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$39.56 in Q3 2025, -$66.7 in Q2 2025, and -$56.75 in Q1 2025.